Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Currently Approved Collection; The National Forensic Laboratory Information System Collection of Drug Analysis Data, 27022-27023 [2018-12444]
Download as PDF
<![CDATA[
27022
Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices
daltland on DSKBBV9HB2PROD with NOTICES
(a) The complainant is: Bear Archery,
Inc., 817 Maxwell Avenue, Evansville,
IN 47706.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
2BULBS Technology Co. Ltd., Qilin
Technology Innovation Park, Nanjing,
Jiangsu, China 210046
Ningbo Linkboy Outdoor Sports Co.,
Ltd, B1, 599 Qiming Road, Xiaying
Town, Yinzhou District, Ningbo,
Zhejiang, China
Shenzhen Keepmyway Tech. Co., Ltd.
Building 2, Bagualing Industrial Zone,
Bagua 2nd Rd., Futian District,
Shenzhen, Guangdong, China 518000
Zhengzhou IRQ Outdoor Sports Co.,
Ltd., Shengshijingwei Building B, No.
18, Xinghua North St., Zhengzhou,
Henan, China
Wenqing Zhang, Room 308, No. 2,
Fuhua Building, Fuhua Road, Futian
District, Shenzhen, Guangdong, China
51800
Tingting Ye, Freecity 659, Huaqiangbei,
Futian District, Shenzhen,
Guangdong, China 51800
Tao Li, Shenzhenshi Longhuaqu
Dalangjiedao, Tongshengshequ
Iinchenggongyeyuan, Disandong 11
Lou Afengeti, Shenzhen, Guangdong,
China 518000
Sean Yuan, 97 Fuzhou South Road,
Jiaozhou, Qingdao, Shandong, China
266300
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW, Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
VerDate Sep<11>2014
19:19 Jun 08, 2018
Jkt 244001
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: June 6, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–12469 Filed 6–8–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0034]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Revision of a
Currently Approved Collection; The
National Forensic Laboratory
Information System Collection of Drug
Analysis Data
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 10, 2018.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Michael J. Lewis, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
SUMMARY:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a currently approved
collection.
2. Title of the Form/Collection: The
National Forensic Laboratory
Information System Collection of Drug
Analysis Data.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Medical Examiner/Coroner Office
Survey; National Forensic Laboratory
Information System Drug Survey of
Drug Laboratories; and Toxicology
Laboratory Survey for the component
within the Department of Justice is the
Drug Enforcement Administration,
Diversion Control Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Affected public (Primary):
Forensic Science Laboratory
Management.
Abstract: The National Forensic
Laboratory Information System (NFLIS)
collections provide the DEA with
national databases on analyzed drug
samples from law enforcement
activities, antemortem toxicology
samples (toxicology laboratories), and
post-mortem toxicology samples
(medical examiner/coroner offices
(MECs) from federal, state, and local
laboratories. Specifically, NFLIS-Drug
data provide DEA current, precise, and
representative estimates of drugs seized
by law enforcement and analyzed by
forensic laboratories. Since 2001, DEA
has had case and drug report estimates
for all drugs reported in NFLIS that are
statistically representative of the nation
and of census regions. The estimates,
which are made possible by updating
the laboratory profiles through the
survey effort (see draft survey in
Appendix), have given DEA the ability
E:\FR\FM\11JNN1.SGM
11JNN1
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices
to track national and regional drug
trends; a clearer national picture of
illicit or diverted drug availability;
additional information about the
temporal changes in drug availability by
geographic region; and the ability to
detect new or emerging drugs.
Information from NFLIS is combined
with other existing databases to develop
more accurate, up-to-date information
on abused drugs. This database
represents a voluntary, cooperative
effort on the part of participating
laboratories and MECs to provide a
centralized source of analyzed drug
data. Existing federal drug abuse
databases do not provide the type,
scope, timeliness, or quality of
information necessary to effectively
estimate the actual or relative abuse
potential of drugs as required under the
Controlled Substances Act (21 U.S.C.
811(b)) and international treaties in a
timely and efficient manner. For
example, much of the trafficking data
for federal drug scheduling actions is
presently obtained on a case-by-case
basis from state and local laboratories.
Occasionally scientific personnel from
the DEA’s Diversion Control Division,
Drug and Chemical Evaluation Section,
have contacted specific laboratories and
requested files. In addition, some DEA
field offices routinely subpoena MEC
records for use in case work. The
development of the National Forensic
Laboratory Information System (NFLIS)
greatly enhances the collection of such
data. Submission of information for this
collection is voluntary. DEA is not
mandating this information collection.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that 140
persons annually for this collection at
1.6 hour per respondent, for an annual
burden of 218 hours.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
that this collection takes 218 annual
burden hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: June 6, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2018–12444 Filed 6–8–18; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
19:19 Jun 08, 2018
Jkt 244001
DEPARTMENT OF JUSTICE
[OMB Number 1121–NEW]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; New
collection: Death in Custody Reporting
Act Collection
Bureau of Justice Assistance,
Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Bureau of Justice Assistance will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The Death in Custody Reporting Act
(DCRA) requires states and federal law
enforcement agencies to report certain
information to the Attorney General
regarding the death of any person
occurring during interactions with law
enforcement officers or while in
custody. See 34 U.S.C. 60105(a) & (b). It
further requires the Attorney General
and the Department of Justice
(Department) to collect the information,
establish guidelines on how it should be
reported, annually determine whether
each state has complied with the
reporting requirements, and address any
state’s noncompliance.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 10, 2018.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Chris Casto, Bureau of Justice
Assistance, 810 Seventh Street NW,
Washington, DC 20531 (email:
DICRAComments@usdoj.gov; telephone:
202–616–6500).
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
SUMMARY:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
27023
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of this information
collection:
1. Type of Information Collection:
New Collection.
2. The Title of the Form/Collection:
Death in Custody Reporting Act
Collection.
3. The agency form number: if any,
and the applicable component of the
Department sponsoring the collection:
DCR–1.
Quarterly Summary. This summary
form requires States to either (1) identify
all reportable deaths that occurred in
their jurisdiction during the
corresponding quarter and provide basic
information about the circumstances of
the death, or (2) affirm that no
reportable death occurred in the State
during the reporting period. For each
quarter in a fiscal year, a State must
complete the Quarterly Summary (Form
DCR–1) and submit it by the reporting
deadline. The Quarterly Summary is a
list of all reportable deaths that occurred
in the State during the corresponding
quarter with basic information about the
circumstances of each death. If a State
did not have a reportable death during
the quarter, the State must so indicate
on the Quarterly Summary. The
reporting deadline to submit the
Quarterly Summary is the last day of the
month following the close of the
quarter. For each quarter, BJA will send
two reminders prior to the reporting
deadline.
Example. The second quarter of a
fiscal year is January 1–March 31. The
deadline to submit the second quarter
Quarterly Summary is April 30. BJA
will send a reminder to States on March
31 and April 15.
Incident Report. This incident report
form requires States to provide
additional information for each
reportable death identified in the
Quarterly Summary that occurred
during interactions with law
enforcement personnel or while in their
custody. For each reportable death
identified in the Quarterly Summary, a
State must complete and submit by the
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 83, Number 112 (Monday, June 11, 2018)]
[Notices]
[Pages 27022-27023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12444]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0034]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Revision of a Currently Approved Collection; The
National Forensic Laboratory Information System Collection of Drug
Analysis Data
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 60 days until
August 10, 2018.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Michael J. Lewis, Diversion
Control Division, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202)
598-6812.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Revision of a currently approved
collection.
2. Title of the Form/Collection: The National Forensic Laboratory
Information System Collection of Drug Analysis Data.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: Medical Examiner/Coroner
Office Survey; National Forensic Laboratory Information System Drug
Survey of Drug Laboratories; and Toxicology Laboratory Survey for the
component within the Department of Justice is the Drug Enforcement
Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract: Affected public (Primary): Forensic Science
Laboratory Management.
Abstract: The National Forensic Laboratory Information System
(NFLIS) collections provide the DEA with national databases on analyzed
drug samples from law enforcement activities, antemortem toxicology
samples (toxicology laboratories), and post-mortem toxicology samples
(medical examiner/coroner offices (MECs) from federal, state, and local
laboratories. Specifically, NFLIS-Drug data provide DEA current,
precise, and representative estimates of drugs seized by law
enforcement and analyzed by forensic laboratories. Since 2001, DEA has
had case and drug report estimates for all drugs reported in NFLIS that
are statistically representative of the nation and of census regions.
The estimates, which are made possible by updating the laboratory
profiles through the survey effort (see draft survey in Appendix), have
given DEA the ability
[[Page 27023]]
to track national and regional drug trends; a clearer national picture
of illicit or diverted drug availability; additional information about
the temporal changes in drug availability by geographic region; and the
ability to detect new or emerging drugs. Information from NFLIS is
combined with other existing databases to develop more accurate, up-to-
date information on abused drugs. This database represents a voluntary,
cooperative effort on the part of participating laboratories and MECs
to provide a centralized source of analyzed drug data. Existing federal
drug abuse databases do not provide the type, scope, timeliness, or
quality of information necessary to effectively estimate the actual or
relative abuse potential of drugs as required under the Controlled
Substances Act (21 U.S.C. 811(b)) and international treaties in a
timely and efficient manner. For example, much of the trafficking data
for federal drug scheduling actions is presently obtained on a case-by-
case basis from state and local laboratories. Occasionally scientific
personnel from the DEA's Diversion Control Division, Drug and Chemical
Evaluation Section, have contacted specific laboratories and requested
files. In addition, some DEA field offices routinely subpoena MEC
records for use in case work. The development of the National Forensic
Laboratory Information System (NFLIS) greatly enhances the collection
of such data. Submission of information for this collection is
voluntary. DEA is not mandating this information collection.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 140 persons annually for this collection at 1.6 hour per
respondent, for an annual burden of 218 hours.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates that this collection
takes 218 annual burden hours.
If additional information is required please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: June 6, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2018-12444 Filed 6-8-18; 8:45 am]
BILLING CODE 4410-09-P
